We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for real-time alerts, custom portfolio, and market movers
The current MAAT market cap is 79.99M. The company's latest EPS is EUR -1.1829 and P/E is -5.83.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 892k | 1.23M | 0 | 972k | 1.43M |
| Operating Income | -4.4M | -4.97M | -5.25M | -8.89M | -13.56M |
| Net Income | -4.48M | -5.84M | -5.3M | -9.02M | -13.71M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 5.89M | 8.17M | 24.28M | 49.42M | 44.73M |
| Total Liabilities | 4.62M | 12.73M | 8.34M | 9.56M | 17.92M |
| Total Equity | 1.27M | -4.56M | 15.94M | 39.86M | 26.81M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.87M | -5.02M | -5.84M | -7.93M | -12.61M |
| Investing | -311k | -154k | -494k | -238k | -815k |
| Financing | 431k | 6.98M | 20.84M | 31.56M | 5.36M |
| Market Cap | 79.99M |
| Price to Earnings Ratio | -5.83 |
| Price to Sales Ratio | 55.92 |
| Price to Cash Ratio | 2.27 |
| Price to Book Ratio | 2.98 |
| Dividend Yield | - |
| Shares Outstanding | 11.59M |
| Average Volume (1 week) | 403 |
| Average Volume (1 Month) | 1.18k |
| 52 Week Change | -21.59% |
| 52 Week High | 11.10 |
| 52 Week Low | 4.50 |
| Spread (Intraday) | 0.06 (0.86%) |
| Company Name | Maat Pharma SA |
| Address |
70 avenue tony garnier lyon, rhone 69007 |
| Website | https://www.maatpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
